Metropolis Healthcare unveils Innovation Cell
July 07, 2022 | Thursday | News
To focus on molecular genomics, superspeciality pathology and companion diagnostics
Image Credit: Shutterstock
Metropolis Healthcare has announced the launch of Metropolis Innovation Cell focusing on molecular genomics, super speciality pathology and companion diagnostics.
Under Innovation Cell, Metropolis is introducing various specialised tests related to pregnancy, cancer, infectious diseases and transplant management.
The company has introduced specialised tests for non-invasive genetic assessments for pregnancy management that can aid in the early detection of chromosomal abnormalities.
It has also launched BRCA1/BRCA 2 Genetic testing for Hereditary Breast and Ovarian Cancer (HBOC), and the molecular oncology pipeline for Lung and common cancers.
